Phase 3 study of GM604 in patients with Amyotrophic lateral sclerosis

Trial Profile

Phase 3 study of GM604 in patients with Amyotrophic lateral sclerosis

Planning
Phase of Trial: Phase III

Latest Information Update: 27 Dec 2016

At a glance

  • Drugs GM 6 (Primary)
  • Indications Amyotrophic lateral sclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Dec 2016 According to a Genervon media release, the company is planning to conduct this trial in 2017.
    • 05 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top